We’re on a mission to make transformative, FDA-approved treatments accessible and more affordable for America’s workforce.
Our first step? GLP-1s for obesity management.
Learn more and join the waitlist: ✨https://t.co/1RsrcCfv47 ✨
#GetCrux#GLP1#Zepbound
“Employers need a better model for offering GLP-1 benefits for obesity management [to] usher in a new era of affordability, access, and better health outcomes.”👏
@RedCellPartners' @grantverstandig shares his thoughts on the GLP-1 affordability problem: https://t.co/n2hBujsrW8
Meet @GetCruxHealth, a benefits platform for employers to offer transformative FDA-approved medications with no rebates, onerous reimbursement processes, or PBM involvement.
Beginning with GLP-1 medications for obesity management, Crux allows employers of all sizes to sign up at no cost to access pass-through drug pricing and contribute non-taxed dollars to further offset employees’ out-of-pocket expenses.
Crux is led by @ChipNash78, @grantverstandig, and Naimish Patel, who previously ran and expanded similar offerings at Rally Health, one of the first consumer-centric digital health companies, which was acquired by @UnitedHealthGrp in 2017.
Employers can join Crux’s waitlist today to be notified when the platform launches (scheduled for early 2026): https://t.co/UM6bmsieOd
Cheers to the @GetCruxHealth team! 🎉
#GLP1 #GetCrux #Zepbound
At Crux, we’re giving employers new, proactive ways to cover the breakthrough therapies that employees want most, starting with GLP-1s for obesity management.
Our waitlist is live, with plans to launch early in 2026. Who’s joining us?
https://t.co/1RsrcCfv47
#GLP1#Zepbound
Introducing Crux: the first no-fee benefit for employers to offer quality-of-life (QoL) therapies at a price that actually makes sense.
Learn more and join the waitlist: ✨https://t.co/1RsrcCfv47 ✨
Read the press release: https://t.co/dTXmRexEbw
#GetCrux